Stock Market Stories and Insights

AIRS
  over a week ago at Macroaxis 
By Gabriel Shpitalnik
As many millenniums are excited about healthcare space, it is only fair to sum up Airsculpt Technologies. We will evaluate why we are still optimistic in anticipation of a recovery. In this post, I will also go over some essential variables affecting Airsculpt Technologies' products, and show how it may impact Airsculpt Technologies outlook for active traders this year.
BTTX
  over a week ago at Macroaxis 
By Raphi Shpitalnik
While some baby boomers are getting worried about healthcare space, it is reasonable to break down Better Therapeutics. We will evaluate why we are still optimistic in anticipation of a recovery. In this post, I will also go over some essential variables affecting Better Therapeutics' products, and show how it may impact Better Therapeutics outlook for active traders this year.
SDPI
  over a week ago at Macroaxis 
By Raphi Shpitalnik
Superior Drilling is scheduled to announce its earnings today. As many passive investors are finally getting excited about energy space, Superior Drilling Products could be a good starting point. Here we also measure the ability of Superior Drilling to meet its long-term debt obligations, such as interest payments on debt, the final principal payment on the debt, and any other fixed obligations like lease payments.
HIPO
  over a week ago at Macroaxis 
By Vlad Skutelnik
Given the investment horizon of 90 days Hippo Holdings is expected to generate 4.45 times more return on investment than the market. However, the company is 4.45 times more volatile than its market benchmark. It trades about -0.02 of its potential returns per unit of risk. The DOW is currently generating roughly -0.08 per unit of risk. As many adventurous traders are excited about financial services space, it is only fair to outline the risk of shorting Hippo Holdings based on its current volatility spike. We will go over a few points Hippo Holdings institutional investors should remember regarding its volatility.
NYC
  over a week ago at Macroaxis 
By Raphi Shpitalnik
Lets try to go over the odds of New York to fully recover from the current slip as its shares went up 3.73%. The entity current daily volatility is 3.09 percent, with a beta of 0.55 and an alpha of -0.1 over DOW. Whilst many millenniums are getting more into saving accounts, it makes sense to go over New York City. We will cover the possibilities of making New York into a steady grower in June.
HNST
  over a week ago at Macroaxis 
By Vlad Skutelnik
As many millenniums are excited about consumer cyclical space, it is only fair to review The Honest. I will take a closer look at this stock and the newest sentiment generated by private investors. Here I will also review some basic indicators that Honest investors should consider in June.
CCLP
  over a week ago at Macroaxis 
By Raphi Shpitalnik
It appears that CSI Compressco may not have a good chance to recover from the recent decline as its shares fell again. CSI Compressco current daily volatility is 2.93 percent, with a beta of 0.5 and an alpha of -0.16 over DOW. While some baby boomers are getting worried growing market volatility, it is reasonable to recap CSI Compressco based on its historical price movement. Why are we still confident in our projection for a recovery.
PLXP
  over a week ago at Macroaxis 
By Vlad Skutelnik
This perspective, will break down some ideas for Plx Pharma investors who consider a position in the firm. We will focus on the cause of why it is still reasonable for the firm to generate above-average margins and lots of cash flow.
LFMD
  over a week ago at Macroaxis 
By Vlad Skutelnik
39% of stocks are less volatile than LifeMD, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. As many old-fashioned traders are trying to avoid healthcare space, it makes sense to digest LifeMD Inc a little further and try to understand its current volatility patterns. We will cover the possibilities of LifeMD's current volatility to continue through June.
EFOI
  over a week ago at Macroaxis 
By Ellen Johnson
While many traders are getting carried away by overanalyzing consumer cyclical space, it is reasonable to concentrate on Energy Focus. We will analyze why it could be a much better year for Energy Focus shareholders. Is Energy Focus valuation justified? I am going to cover the firm perspective on valuation to give you a better outlook on taking a position in it.